Core Laboratories (CLB) Earning Somewhat Positive News Coverage, Study Shows

News articles about Core Laboratories (NYSE:CLB) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Core Laboratories earned a news impact score of 0.15 on Accern’s scale. Accern also gave news stories about the oil and gas company an impact score of 46.4413785344442 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

A number of equities analysts have recently commented on CLB shares. Scotiabank set a $136.00 price target on shares of Core Laboratories and gave the stock a “hold” rating in a report on Wednesday, October 25th. Zacks Investment Research lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Piper Jaffray Companies set a $97.00 price target on shares of Core Laboratories and gave the stock a “hold” rating in a report on Monday, October 23rd. Royal Bank Of Canada reiterated a “buy” rating and set a $115.00 price target on shares of Core Laboratories in a report on Friday, September 1st. Finally, Cowen reiterated a “hold” rating and set a $100.00 price target on shares of Core Laboratories in a report on Friday, September 1st. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $108.64.

Core Laboratories (NYSE:CLB) traded up $0.64 on Thursday, reaching $99.29. 508,323 shares of the company’s stock traded hands, compared to its average volume of 576,162. Core Laboratories has a 12-month low of $86.55 and a 12-month high of $125.83. The company has a current ratio of 2.18, a quick ratio of 1.81 and a debt-to-equity ratio of 1.53. The company has a market capitalization of $4,519.37, a P/E ratio of 55.94 and a beta of 1.56.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.04. Core Laboratories had a net margin of 12.06% and a return on equity of 52.89%. The firm had revenue of $166.20 million during the quarter, compared to the consensus estimate of $160.94 million. During the same period in the previous year, the firm posted $0.38 earnings per share. The business’s revenue was up 1.4% compared to the same quarter last year. analysts forecast that Core Laboratories will post 1.99 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 21st. Shareholders of record on Friday, October 20th were paid a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 2.22%. The ex-dividend date was Thursday, October 19th. Core Laboratories’s dividend payout ratio (DPR) is currently 126.44%.

COPYRIGHT VIOLATION NOTICE: “Core Laboratories (CLB) Earning Somewhat Positive News Coverage, Study Shows” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Insider Buying and Selling by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with's FREE daily email newsletter.

Leave a Reply